Send to:

Choose Destination
See comment in PubMed Commons below
Am J Ophthalmol. 2007 Apr;143(4):687-9. Epub 2006 Dec 20.

Statin use and the long-term risk of incident cataract: the Blue Mountains Eye Study.

Author information

  • 1Centre for Vision Research, Department of Ophthalmology, Westmead Millennium Institute, University of Sydney, Australia.



To assess the association between statin use and long-term incident cataract.


Population-based cohort study.


Of 3,654 baseline (1992 to 1994) elderly participants in the Blue Mountains Eye Study (BMES), 2,335 (75% of survivors) were reexamined after five years (1997 to 1999) and 1,952 (76% of survivors) after 10 years (2002 to 2004). Lens photographs were taken and graded using the Wisconsin Cataract Grading System. History, physical examination, and fasting blood samples provided data on possible risk factors. Discrete linear logistic models were used to assess the risk of cataract.


After controlling for age, gender, and other factors, statin use was protective for any cataract (hazard ratio [HR] 0.52; 95% confidence interval [CI] 0.29-0.93), but was not significantly associated with incident nuclear (HR 0.66; CI 0.35 to 1.25), cortical (HR 0.76; CI 0.44 to 1.33), or posterior subcapsular (PSC) cataract (HR 1.47; CI 0.70 to 3.08).


Statin use was found to reduce by 50% the risk of cataract development, principally nuclear or cortical cataract subtypes.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk